Dr. Zehnder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Palo Alto, CA 94305
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1991 - 1993- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 1988 - 1991
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1984 - 1988
Tufts University School of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 1985 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
- Evaluation of Pathwork Tissue of Origin (TOO) Test for Human Malignancies Start of enrollment: 2008 Feb 01
- Integrated Whole-Genome Analysis of Hematologic Disorders Start of enrollment: 2009 Sep 01
- Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin Mimetics Start of enrollment: 2012 Jul 01
Publications & Presentations
PubMed
- p53 immunohistochemistry as an ancillary tool for rapid assessment of residual disease in TP53-mutated acute myeloid leukemia and myelodysplastic syndromes.Nivaz Brar, Lauren Lawrence, Eula Fung, James L Zehnder, Peter L Greenberg
American Journal of Clinical Pathology. 2024-09-03 - Impact of C-reactive Protein on Anticoagulation Monitoring in Extracorporeal Membrane Oxygenation.Jai Madhok, Christian O'Donnell, Jing Jin, Clark G Owyang, Jonathan M Weimer
Journal of Cardiothoracic and Vascular Anesthesia. 2024-09-01 - Discordant High Activated Partial Thromboplastin Time Relative to Anti-Xa Values in Hospitalized Patients is an Independent Risk Factor for Increased 30-day Mortality.Jing Jin, Santosh Gummidipundi, Joe Hsu, Husham Sharifi, Derek Boothroyd
Seminars in Thrombosis and Hemostasis. 2024-08-27
Abstracts/Posters
- Increased Mortality and Bleeding in a Large Cohort of Patients on Heparin Anticoagulation Therapy with Discordant Anti-Factor Xa Activity and Activated Partial Thrombo...James Zehnder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Other
- Cytogenetic and molecular genetic diagnostic toolsZehnder JL, Cherry AM, Schrijver I
http://www.uptodate.com/contents/cytogenetic-and-molecular-genetic-diagnostic-tools
UpToDate, Wolters Kluwer Health - 2012-11-02 - Bone marrow aspiration and biopsy: Indications and techniqueZehnder JL
http://www.uptodate.com/contents/bone-marrow-aspiration-and-biopsy-indications-and-technique
UpToDate, Wolters Kluwer Health - 2013-04-10 - Clinical use of coagulation testsZehnder JL
http://www.uptodate.com/contents/clinical-use-of-coagulation-tests
UpToDate, Wolters Kluwer Health - 2012-12-31 - Join now to see all
Press Mentions
Some Bay Area Hospitals Return COVID Tests Results Within an Hour. Here's Why It's Not More CommonSeptember 11th, 2021- What Are at-Home COVID Tests?August 16th, 2021
- Stanford Experts Encourage Continued Vaccination After Johnson & Johnson Pause LiftedApril 26th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
